Investigational Approaches for Treating T1D
Schafer Boeder, MD, and Egils K. Bogdanovics, MD, share approaches to prevention, preservation, and replacement therapies for the treatment of T1D.
Stay updated with breaking news from Steve Edelman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Schafer Boeder, MD, and Egils K. Bogdanovics, MD, share approaches to prevention, preservation, and replacement therapies for the treatment of T1D.
Expert endocrinologists provide final thoughts on addressing unmet needs and improving the management of T1D.
Egils K. Bogdanovics, MD, and the expert panel review the TN10 study data on the efficacy of teplizumab in delaying the progression of T1D, which led to the drug’s approval from the FDA.
Linda A. DiMeglio, MD, reviews screening options for patients with a family history of T1D, highlighting TrialNet.
Justin M. Gregory, MD, MSC, reviews the risk factors of T1D, highlighting a family history of T1D and antibody screening.